Cognitive Impairment Assessment in Breast Cancer Survivors
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-65
SponsorEuropean Institute of Oncology
About this trial
This study is a monocentric, observational, cross-sectional study with a case-control design, aimed at evaluating the construct validity, discriminative ability, and diagnostic accuracy of a second-level neuropsychological test battery for the detection of cancer-related cognitive impairment in breast cancer survivors.
Eligibility criteria
Qualifiers
Age between 18 and 65 years old
Patient with a previous documented diagnosis of non-metastatic breast cancer (only for breast cancer survivor gruop)
Patient has completed chemotherapy for at least 6 months and for a maximum of 36 months if planned (only for breast cancer survivor gruop)
Understanding of the Italian language and ability to give informed consent
Disqualifiers
Presence of brain metastases or history of brain radiation therapy (only for breast cancer survivor gruop)
Patient with previous diagnosis of other malignant tumors in addition to breast cancer (only for breast cancer survivor gruop)
Patient with a previous diagnosis of malignant carcinomas (only for control gruop)
Patient with a history of brain damage with unresolved neurological consequences
Trial design
Treatments tested in this trial
- Not listed
Trial groups
200 Participants
are grouped into 2 trial groupsSponsors and collaborators
Source ClinicalTrials.gov